Edition No. 60 · Fri 21 Aug 2026 · Story 22 of 24
"Moderna, Merck cancer vaccine shows initial late-stage melanoma data"
CNBC
Moderna and Merck reported an experimental mRNA vaccine prevented the return and spread of skin cancer in high-risk patients.